We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.86B
| $916K | ﹤0.01% |
24,030
-726
| -3% | -$27.4K |
|
|
JAMF
3352
DELISTED
Jamf
JAMF
| $916K | ﹤0.01% |
+27,276
| New | +$929K |
|
3353
PUT
Intercontinental Exchange
ICE
$84.1B
| $914K | ﹤0.01% |
7,700
| – | – |
|
3354
Anavex Life Sciences
AVXL
$297M
| $913K | ﹤0.01% |
+39,930
| New | +$591K |
|
3355
Liberty Energy
LBRT
$3.17B
| $913K | ﹤0.01% |
64,617
+11,601
| +22% | +$157K |
|
3356
PUT
Dollar General
DG
$28B
| $911K | ﹤0.01% |
+4,200
| New | +$882K |
|
3357
CALL
Red Robin
RRGB
$151M
| $911K | ﹤0.01% |
+27,500
| New | +$938K |
|
|
3358
PUT
Red Robin
RRGB
$151M
| $911K | ﹤0.01% |
+27,500
| New | +$938K |
|
|
DHIL
3359
DELISTED
Diamond Hill
DHIL
| $910K | ﹤0.01% |
5,443
-391
| -7% | -$66.9K |
|
3360
Theravance Biopharma
TBPH
$876M
| $910K | ﹤0.01% |
62,722
+13,888
| +28% | +$261K |
|
3361
Heritage Financial
HFWA
$1.23B
| $906K | ﹤0.01% |
36,197
-10,741
| -23% | -$299K |
|
3362
Gold Fields
GFI
$33.4B
| $901K | ﹤0.01% |
101,595
-3,321
| -3% | -$34.4K |
|
3363
Monarch Casino & Resort
MCRI
$2.18B
| $901K | ﹤0.01% |
13,612
-5,327
| -28% | -$368K |
|
|
MGIC
3364
DELISTED
Magic Software Enterprises
MGIC
| $901K | ﹤0.01% |
55,517
+25,528
| +85% | +$409K |
|
|
CMBT
3365
CMB.TECH NV
CMBT
$4.62B
| – | – |
-401,346
| Closed | -$3.66M |
|
3366
Adtran
ADTN
$641M
| $900K | ﹤0.01% |
43,582
-1,050
| -2% | -$20.3K |
|
3367
DMC Global
BOOM
$150M
| $898K | ﹤0.01% |
15,957
+2,451
| +18% | +$135K |
|
|
ANAT
3368
DELISTED
American National Group, Inc. Common Stock
ANAT
| $896K | ﹤0.01% |
6,035
-3,731
| -38% | -$499K |
|
3369
StoneX
SNEX
$9.2B
| $893K | ﹤0.01% |
74,490
-15,825
| -18% | -$204K |
|
3370
Tucows
TCX
$157M
| $893K | ﹤0.01% |
11,133
-1,820
| -14% | -$144K |
|
3371
Utz Brands
UTZ
$1.25B
| $893K | ﹤0.01% |
40,197
-7,214
| -15% | -$180K |
|
3372
Kforce
KFRC
$1.05B
| $890K | ﹤0.01% |
14,148
-920
| -6% | -$54.5K |
|
|
MTA
3373
Metalla Royalty & Streaming
MTA
$784M
| $890K | ﹤0.01% |
+103,973
| New | +$1.01M |
|
|
ICAD
3374
DELISTED
iCAD Inc
ICAD
| $889K | ﹤0.01% |
+51,324
| New | +$900K |
|
|
VXRT
3375
DELISTED
Vaxart
VXRT
| $889K | ﹤0.01% |
118,665
-5,740
| -5% | -$40.1K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.